Recorded Chinese product: 复方氨林巴比妥注射液复方氨林巴比妥注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

安替比林是一种在国家药监局注册认定的药品。该药品含有安替比林、巴比妥-5f2e1bce等成分。

该药品关联的活性成分包括:安替比林Anti Bilin、巴比妥Babi Tuo。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:邢台国鑫制药有限公司Chinese legal name: 邢台国鑫制药有限公司。

您可以探索含有相同成分的其他药品:安替比林-d17dc7be成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 复方氨林巴比妥注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 安替比林Anti Bilin, 巴比妥Babi Tuo.

Manufacturers recorded for this product: 邢台国鑫制药有限公司Chinese legal name: 邢台国鑫制药有限公司.

Explore other medicines containing the same ingredient: 安替比林 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 复方氨林巴比妥注射液Recorded Chinese product: 复方氨林巴比妥注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 2ml2 mL

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 邢台国鑫制药有限公司Chinese legal name: 邢台国鑫制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H13024616

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H13024616

Manufacturer

Chinese legal name: 邢台国鑫制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H13024616

生产企业

邢台国鑫制药有限公司(国产)

适应症

本品主要用于急性高热时的紧急退热,对发热时的头痛症状也有缓解作用。

用法用量

肌内注射:成人一次2ml(1支);或遵医嘱。在监护情况下极量为一日6ml(3支)。|1.2岁以下:一次0.5~1ml(1/4~1/2支);|2.2~5岁:一次1~2ml(1/2~1支);|3.大于5岁:一次2ml(1支)。本品不宜连续使用。

不良反应

1.过敏性休克,表现为胸闷、头晕、恶心呕吐、血压下降、大汗淋漓等症状,应立即停药并抢救。2.粒细胞缺乏,紫癜,有时急性起病。3.皮疹、荨麻疹、表皮松解症等。

禁忌

1.对吡唑酮类或巴比妥类药物过敏者禁用。2.对本品有过敏史者禁用。

注意事项

1.肌内注射前应向病人询问是否有吡唑酮类或巴比妥类药物过敏史,有过敏史者应避免使用本品,过敏性体质者亦应慎用。2.不得与其他药物混合注射。3.长期使用可引起粒细胞减少,再生障碍性贫血及肝肾损坏等严重中毒反应。4.呼吸系统有严重疾病及呼吸困难者慎用本品。5.体弱者慎用。6.本品仅对症治疗,在解除高热症状后对因治疗,在应用本品无明显效果时应改用其他方法治疗,避免盲目大量应用本品。

贮藏

遮光,密闭保存。

规格

2ml

证据Evidence

  • 批准文号: 国药准字H13024616
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.